Washington University Institute of Clinical and Translational Sciences
华盛顿大学临床与转化科学研究所
基本信息
- 批准号:10556449
- 负责人:
- 金额:$ 1016.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-06-19 至 2027-02-28
- 项目状态:未结题
- 来源:
- 关键词:AddressAdoptedAdvocateAffectBiological FactorsBiometryClinicClinicalClinical ResearchClinical SciencesClinical TrialsClinical and Translational Science AwardsCollaborationsCommunitiesCommunity HealthComplexData SetDevelopmentDiseaseDissemination and ImplementationEcosystemElderlyEnsureEnvironmental Risk FactorFacultyFoundationsGenomicsGoalsHealthHealthcareHealthcare SystemsHomeHumanIllinoisIndividualIndustryInformaticsInfrastructureInstitutesInstitutionInterdisciplinary StudyInterventionKnowledgeLaboratoriesLifeLogisticsLongevityMentorsMethodologyMethodsMissouriMulti-Institutional Clinical TrialOutcomeParticipantPatientsPopulationPopulation HeterogeneityPowder dose formProcessProductivityResearchResearch PersonnelResourcesRural PopulationSaintsScienceSocioeconomic FactorsSpecial PopulationTarget PopulationsTechnologyTimeTrainingTraining ProgramsTranslatingTranslational ResearchTranslationsUniversitiesUrban PopulationWashingtonWorkWorkforce Developmentarchive dataarchived databaseclinical practicecommunity engagementdata integrationdigitaldissemination sciencediverse dataeducation researchfundamental researchgenome scienceshealth differencehealth disparityimplementation designimplementation scienceimprovedinformatics toolinnovationinteroperabilitymultidisciplinarymultiscale dataprogramsrural environmentsocial determinantstranslational impacturban setting
项目摘要
Contact PD/PI: Powderly, William G.
Overall Component, 7. Project Summary/Abstract:
The Institute of Clinical and Translational Sciences aligns with the CTSA goals of developing innovative
solutions to improve the efficiency, quality, and impact of translational science. We will pursue five aims:
Aim 1: Advance interdisciplinary programs to develop, promote, mentor, and retain highly qualified
and diverse faculty, trainees, and staff who translate scientific discoveries into action, thereby
becoming agents for change in their institutions and communities. We will enhance our existing research
education and training programs, expand and diversify our workforce, and promote team science approaches
to conduct and translate high-impact research that has the potential for changing the health of our community.
(Translational Workforce Development).
Aim 2: Facilitate research designed for implementation by engaging diverse communities and
stakeholders in multidisciplinary collaborative teams at all stages of the translational research
process, thereby demonstrating the benefit and impact of translational science. We will improve
community health by collaborating with patient advocates, developing new partnerships, advancing the science
of collaboration, and capitalizing on strengths in implementation science (Collaboration and Engagement).
Aim 3: Integrate research across individual lifespans and apply translational science in complex and
diverse populations to improve individual and community health through meaningful research
collaborations and sustainable partnerships. We will address health disparities across the lifespan and
among special populations, identify challenges that differentially affect urban and rural populations, catalyze
the formation of transdisciplinary teams, and evaluate the outcomes of our work (Integration).
Aim 4: Drive innovation, quality, efficiency, and inclusion in translational research to enhance
collaborations and catalyze the implementation of discovery science. We will solve key logistical
roadblocks in translational science and implement innovative methods to engage stakeholders and research
participants, thereby targeting different populations, life stages, and health states (Methods and Processes).
Aim 5: Apply innovative informatics and biostatistics solutions to improve quality and efficiency at
every stage of translational research, and create an ecosystem that integrates diverse data and
facilitates the interoperability, use, and reuse of digital assets. We will ensure the interoperability of
current and archived data sets, implement new informatics technologies to enhance investigator productivity,
and promote the formation of interdisciplinary research teams (Informatics).
Impact. Successful completion of these five aims will transform translational research, accelerate the
dissemination of new innovations across our entire population, and strengthen and diversify our workforce.
Project Summary/Abstract Page 235
Contact PD/PI: Powderly, William G.
Overall Component
8.
联系PD/PI:Powderly,William G.
整体结构,7。项目概要/摘要:
临床和转化科学研究所与CTSA的目标一致,即开发创新的
提高转化科学的效率、质量和影响力的解决方案。我们将追求五个目标:
目标1:推进跨学科项目,以发展、促进、指导和留住高素质人才
以及将科学发现转化为行动的各种教师、学员和工作人员,
成为其机构和社区变革的推动者。我们将加强现有的研究
教育和培训计划,扩大和多样化我们的劳动力,并促进团队科学的方法
开展和翻译具有改变我们社区健康潜力的高影响力研究。
(翻译人才发展)。
目标2:通过让不同社区参与,促进为执行而设计的研究,
在翻译研究的各个阶段的多学科合作团队的利益相关者
过程,从而证明了转化科学的好处和影响。完善
通过与患者倡导者合作,发展新的伙伴关系,推进科学,
协作,并利用实施科学的优势(协作和参与)。
目标3:整合跨个人生命周期的研究,并在复杂和复杂的环境中应用转化科学。
通过有意义的研究改善个人和社区健康
合作和可持续的伙伴关系。我们将解决整个生命周期的健康差距,
在特殊人群中,确定对城市和农村人口产生不同影响的挑战,
组建跨学科团队,并评估我们的工作成果(整合)。
目标4:推动转化研究的创新、质量、效率和包容性,
合作和促进发现科学的实施。我们会解决关键的后勤问题
在转化科学的障碍,并实施创新的方法,使利益相关者和研究
参与者,从而针对不同的人群,生命阶段和健康状态(方法和过程)。
目标5:应用创新的信息学和生物统计学解决方案,提高质量和效率,
每个阶段的转化研究,并创建一个生态系统,整合不同的数据,
促进数字资产的互操作性、使用和重用。我们将确保
现有和存档的数据集,采用新的信息技术,以提高调查人员的生产力,
促进跨学科研究团队(信息学)的形成。
冲击成功完成这五个目标将改变转化研究,加速
在我们的全体人口中传播新的创新,加强我们的劳动力队伍并使之多样化。
项目摘要/摘要第235页
联系PD/PI:Powderly,William G.
总体组件
8.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William G. Powderly其他文献
Trimetrexate with leucovorin versus trimethoprim-sulfamethoxazole for moderate to severe episodes of Pneumocystis carinii pneumonia in patients with AIDS: a prospective, controlled multicenter investigation of the AIDS Clinical Trials Group Protocol 029/031.
三甲曲沙联合甲酰四氢叶酸与甲氧苄氨嘧啶-磺胺甲恶唑治疗艾滋病患者中度至重度卡氏肺孢子虫肺炎发作:艾滋病临床试验组方案 029/031 的一项前瞻性、对照多中心研究。
- DOI:
10.1093/infdis/170.1.165 - 发表时间:
1994 - 期刊:
- 影响因子:0
- 作者:
Fred R. Sattler;Peter T. Frame;R. Davis;Larry Nichols;Brent Shelton;B. Akil;Robert P. Baughman;C. Hughlett;Walter Weiss;C. Boylen;C. V. D. Horst;John H. Black;William G. Powderly;Roy T. Steigbigel;J. Leedom;Henry Masur;Judith Feinberg - 通讯作者:
Judith Feinberg
Cyclic AMP Cyclic GMP VASCULAR tone isregulated by a variety of vasoactive mol cules : neurotransmitters
Cyclic AMP Cyclic GMP 血管张力受多种血管活性分子:神经递质调节
- DOI:
- 发表时间:
2008 - 期刊:
- 影响因子:0
- 作者:
P. Tebas;A. Patick;E. Kane;Michael Klebert;Janet H. Simpson;Alejo Erice;William G. Powderly;Keith Henry - 通讯作者:
Keith Henry
When to start antiretroviral therapy: asking the right question
何时开始抗逆转录病毒治疗:提出正确的问题
- DOI:
10.2217/fvl.11.26 - 发表时间:
2011 - 期刊:
- 影响因子:3.1
- 作者:
William G. Powderly - 通讯作者:
William G. Powderly
Virologic responses to a ritonavir--saquinavir-containing regimen in patients who had previously failed nelfinavir.
先前奈非那韦治疗失败的患者对含利托那韦-沙奎那韦疗法的病毒学反应。
- DOI:
- 发表时间:
1999 - 期刊:
- 影响因子:0
- 作者:
P. Tebas;A. Patick;E. Kane;Michael Klebert;Janet H. Simpson;Alejo Erice;William G. Powderly;Keith Henry - 通讯作者:
Keith Henry
Efficacy of Infliximab, Abatacept, and Cenicriviroc for the Treatment of Adults Hospitalized with COVID-19 Pneumonia
英夫利昔单抗、阿巴西普和西尼立韦罗治疗因 COVID-19 肺炎住院的成人的疗效
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:8.4
- 作者:
Dan;Jianqiao Wang;Kevin J. Anstrom;Lisa M. LaVange;Jun Wen;Samuel A. Bozzette;William G. Powderly - 通讯作者:
William G. Powderly
William G. Powderly的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William G. Powderly', 18)}}的其他基金
Washington University Institute of Clinical and Translational Sciences
华盛顿大学临床与转化科学研究所
- 批准号:
10827727 - 财政年份:2023
- 资助金额:
$ 1016.11万 - 项目类别:
Washington University Institute of Clinical and Translational Sciences
华盛顿大学临床与转化科学研究所
- 批准号:
10700256 - 财政年份:2022
- 资助金额:
$ 1016.11万 - 项目类别:
WASHINGTON UNIVERSITY INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCES
华盛顿大学临床与转化科学研究所
- 批准号:
10321102 - 财政年份:2017
- 资助金额:
$ 1016.11万 - 项目类别:
Washington University Institute of Clinical Translational Sciences
华盛顿大学临床转化科学研究所
- 批准号:
9889200 - 财政年份:2017
- 资助金额:
$ 1016.11万 - 项目类别:
Washington University Institute of Clinical and Translational Sciences
华盛顿大学临床与转化科学研究所
- 批准号:
10598597 - 财政年份:2017
- 资助金额:
$ 1016.11万 - 项目类别:
WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCES
吴氏临床与转化科学研究所
- 批准号:
10217859 - 财政年份:2017
- 资助金额:
$ 1016.11万 - 项目类别:
Rosiglitazone & Exercise Training: Effects on HIV-Infected People
罗格列酮
- 批准号:
6971952 - 财政年份:2004
- 资助金额:
$ 1016.11万 - 项目类别:
STUDY OF ONCE-WEEKLY ALENDRONATE IN HIV-INFECTED SUBJECTS
HIV 感染者每周一次阿仑膦酸钠的研究
- 批准号:
6971984 - 财政年份:2004
- 资助金额:
$ 1016.11万 - 项目类别:
WU 122: EVALUATE METABOLIC EFFECTS OF DISCONTINUATION OF ANTIRETROVIRAL THERAPY
WU 122:评估停止抗逆转录病毒治疗的代谢影响
- 批准号:
6971971 - 财政年份:2004
- 资助金额:
$ 1016.11万 - 项目类别:
相似海外基金
How novices write code: discovering best practices and how they can be adopted
新手如何编写代码:发现最佳实践以及如何采用它们
- 批准号:
2315783 - 财政年份:2023
- 资助金额:
$ 1016.11万 - 项目类别:
Standard Grant
One or Several Mothers: The Adopted Child as Critical and Clinical Subject
一位或多位母亲:收养的孩子作为关键和临床对象
- 批准号:
2719534 - 财政年份:2022
- 资助金额:
$ 1016.11万 - 项目类别:
Studentship
A material investigation of the ceramic shards excavated from the Omuro Ninsei kiln site: Production techniques adopted by Nonomura Ninsei.
对大室仁清窑遗址出土的陶瓷碎片进行材质调查:野野村仁清采用的生产技术。
- 批准号:
20K01113 - 财政年份:2020
- 资助金额:
$ 1016.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A comparative study of disabled children and their adopted maternal figures in French and English Romantic Literature
英法浪漫主义文学中残疾儿童及其收养母亲形象的比较研究
- 批准号:
2633211 - 财政年份:2020
- 资助金额:
$ 1016.11万 - 项目类别:
Studentship
A comparative study of disabled children and their adopted maternal figures in French and English Romantic Literature
英法浪漫主义文学中残疾儿童及其收养母亲形象的比较研究
- 批准号:
2436895 - 财政年份:2020
- 资助金额:
$ 1016.11万 - 项目类别:
Studentship
A comparative study of disabled children and their adopted maternal figures in French and English Romantic Literature
英法浪漫主义文学中残疾儿童及其收养母亲形象的比较研究
- 批准号:
2633207 - 财政年份:2020
- 资助金额:
$ 1016.11万 - 项目类别:
Studentship
A Study on Mutual Funds Adopted for Individual Defined Contribution Pension Plans
个人设定缴存养老金计划采用共同基金的研究
- 批准号:
19K01745 - 财政年份:2019
- 资助金额:
$ 1016.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The limits of development: State structural policy, comparing systems adopted in two European mountain regions (1945-1989)
发展的限制:国家结构政策,比较欧洲两个山区采用的制度(1945-1989)
- 批准号:
426559561 - 财政年份:2019
- 资助金额:
$ 1016.11万 - 项目类别:
Research Grants
Securing a Sense of Safety for Adopted Children in Middle Childhood
确保被收养儿童的中期安全感
- 批准号:
2236701 - 财政年份:2019
- 资助金额:
$ 1016.11万 - 项目类别:
Studentship
Structural and functional analyses of a bacterial protein translocation domain that has adopted diverse pathogenic effector functions within host cells
对宿主细胞内采用多种致病效应功能的细菌蛋白易位结构域进行结构和功能分析
- 批准号:
415543446 - 财政年份:2019
- 资助金额:
$ 1016.11万 - 项目类别:
Research Fellowships














{{item.name}}会员




